Specialist · Toronto, ON
Genesys Capital Management
Creating and building life science companies since 2000.
- Cheque
- $1M to $10M
- Role
- Can lead a round
- Pace
- Selective right now
- Kind
- Specialist
- Based in
- Toronto, ON
- Vehicle size
- $30M
- Founded
- 2000
- Works in
- EN
- Last deal seen
- January 2026
- Stages
- Seed, Series A, Series B and later
- Sectors
- Health and biotech
Their thesis, in full
Pure-play life sciences VC founded in 2000 in Toronto, investing in and building early-stage biotech, pharma and medtech companies addressing unmet medical needs via a create-and-build strategy. Over $400M raised across six funds, with 20 exits including Fusion Pharmaceuticals (AstraZeneca, $2.4B) and Inversago Pharma (Novo Nordisk, $1.1B). Led Enspire DBS Therapy's Series B1 in January 2026.
What they bring past the cheque
- Life science co-creation
- BDC-backed platform
- 25-year biotech track record
- Clinical development guidance
- Therapeutics syndicate access
Questions they usually ask
Have an answer ready for each one before the first call.
- What is the unmet medical need and how does your asset compare to the current standard of care?
- How does your preclinical data package read against what a strategic acquirer needs to see?
- Are you open to a co-creation model where we help build the company around the science?
Follow-on
Genesys reserves meaningful capital from Fund IV to follow its co-created portfolio through clinical milestones and into Series B and beyond, often alongside syndicate partners such as Fonds de solidarite FTQ, Arboretum Ventures and iGan Partners. Founders are expected to share clinical and regulatory milestones tightly with the team.
Portfolio
Names they back, most notable first.
- Fusion PharmaceuticalsExit · 2024
- Inversago PharmaExit · 2023
- Profound MedicalPublic
- Feldan Therapeutics
- Flosonics Medical
Similar investors
Overlapping sectors and stages. Useful to build a list of 10 to 20 names for one round.
See how they fit your round
Set your stage, sector and amount once. Fractal App tells you if Genesys Capital Management can lead it, tracks every follow-up, and counts the days of silence. Free, no card.
Open in the app →